Back to Search
ANDREW MILLER, DMD
DMD
Dentist
NPI: 1497010292Individual
Specialties, Licenses & Credentials
DentistPrimary
Dentist
Code: 122300000X
DL 11602(MA)
Clinical Trials (4)
4
Linked Trials
0
Recruiting
4
With Results
A Study of Infliximab for Treatment Resistant Major Depression
NCT00463580COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Bupropion Versus Escitalopram on Reward Circuitry and Motivational Deficits
NCT04352101COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Effects of Riluzole on CNS Glutamate and Fatigue in Breast Cancer Survivors With High Inflammation
NCT02796755COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Effectiveness of Escitalopram in Preventing or Reducing Depressive Symptoms in People Receiving Interleukin-2 Treatment
NCT00352885COMPLETEDPHASE4STUDY_CHAIR
Research & Publications (20)
Antidepressants for the treatment of depression in people with cancer.
PMID 36999619·Cochrane Database Syst Rev·2023
6-review
Inhibition of tumor necrosis factor improves sleep continuity in patients with treatment resistant depression and high inflammation.
PMID 25529904·Brain Behav Immun·2015
2-rct
Transcriptional signatures related to glucose and lipid metabolism predict treatment response to the tumor necrosis factor antagonist infliximab in patients with treatment-resistant depression.
PMID 23624296·Brain Behav Immun·2013
2-rct
The impact of escitalopram on IL-2-induced neuroendocrine, immune, and behavioral changes in patients with malignant melanoma: preliminary findings.
PMID 23575741·Neuropsychopharmacology·2013
2-rct
A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers.
PMID 22945416·JAMA Psychiatry·2013
4-observational
Neurobehavioral effects of interferon-α in patients with hepatitis-C: symptom dimensions and responsiveness to paroxetine.
PMID 22353759·Neuropsychopharmacology·2012
4-observational
Sumoylation of MITF and its related family members TFE3 and TFEB.
PMID 15507434·J Biol Chem·2005
8-other
Transcriptional regulation of the melanoma prognostic marker melastatin (TRPM1) by MITF in melanocytes and melanoma.
PMID 14744763·Cancer Res·2004
7-preclinical
Residential mobility during pregnancy: patterns and correlates.
PMID 19568920·Matern Child Health J·2010
8-other
Spatial scale and opportunities for choice influence browsing and associational refuges of focal plants.
PMID 19594661·J Anim Ecol·2009
7-preclinical
Shellfish face uncertain future in high CO2 world: influence of acidification on oyster larvae calcification and growth in estuaries.
PMID 19478855·PLoS One·2009
7-preclinical
Lip reconstruction with combined cutaneous and mucosal pedicle flaps.
PMID 19438674·Dermatol Surg·2009
5-case
Interrater variability of a severity-of-illness score in critically ill adults.
PMID 19255101·Am J Crit Care·2009
8-other
Histologic and immunohistochemical characterization of pheochromocytoma in 6 cotton-top tamarins (Saguinus oedipus).
PMID 19605896·Vet Pathol·2009
7-preclinical
Block copolymer micelles as nanocontainers for controlled release of proteins from biocompatible oil phases.
PMID 19235932·Biomacromolecules·2009
7-preclinical
Pharmacokinetics of chlorproguanil, dapsone, artesunate and their major metabolites in patients during treatment of acute uncomplicated Plasmodium falciparum malaria.
PMID 19517101·Eur J Clin Pharmacol·2009
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 30 E CONCORD ST APT 5
BOSTON, MA 02118 - Phone
- (617) 997-5501
Quick Facts
- NPI
- 1497010292
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Clinical Trials
- 4
- Publications
- 20
Are you this provider?
Claim Your Profile